Literature DB >> 27573801

Mast Cell - Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications.

Stephen D Skaper1.   

Abstract

Mast cells and microglia, working singly and in partnership, produce proinflammatory agents which play key roles in a wide array of nervous system disorders. Such neuroinflammatory settings may compromise integrity of both the blood-nerve barrier and blood-brain barrier (BBB) and blood-spinal cord barrier. While both belong to the innate immune system mast cells are far more ubiquitous, are resident in peripheral nerves and the central nervous system, and can influence blood-nerve barrier characteristics. Mast cells, being near the perivasculature especially within the dura, on the brain side of the BBB, are strategically located to play havoc with the BBB. Mast cells and glia are endowed with homeostatic mechanisms/molecules which come into play following tissue damage. These include the N-acylethanolamine family, especially N-palmitoylethanolamine, which is posited to be a key player in maintaining cellular homeostasis against external stressors provoking, for example, inflammation. This review is intended as an overview covering the pathobiology of neuroinflammation in the context of mast cells and microglia, their role in BBB integrity, and therapeutic perspectives in targeting these cells to preserve BBB function.

Entities:  

Mesh:

Year:  2016        PMID: 27573801     DOI: 10.2174/1871527315666160829105533

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  9 in total

Review 1.  Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Govindhasamy P Selvakumar; Smita Zaheer; Mohammad E Ahmed; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Prashant A Natteru; Shankar Iyer; Asgar Zaheer
Journal:  Front Cell Neurosci       Date:  2017-07-24       Impact factor: 5.505

Review 2.  Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis.

Authors:  Duraisamy Kempuraj; Govindhasamy P Selvakumar; Ramasamy Thangavel; Mohammad E Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Shankar S Iyer; Sachin M Bhagavan; Swathi Beladakere-Ramaswamy; Asgar Zaheer
Journal:  Front Neurosci       Date:  2017-12-12       Impact factor: 4.677

Review 3.  Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases.

Authors:  Giovanna Traina
Journal:  Front Cell Neurosci       Date:  2019-07-30       Impact factor: 5.505

Review 4.  ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain.

Authors:  Ramona D'Amico; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

5.  Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer's Disease.

Authors:  Duraisamy Kempuraj; Shireen Mentor; Ramasamy Thangavel; Mohammad E Ahmed; Govindhasamy Pushpavathi Selvakumar; Sudhanshu P Raikwar; Iuliia Dubova; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  Front Cell Neurosci       Date:  2019-02-19       Impact factor: 5.505

6.  Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain - Sciatica.

Authors:  Giorgio Cruccu; Giulia Di Stefano; Paolo Marchettini; Andrea Truini
Journal:  CNS Neurol Disord Drug Targets       Date:  2019       Impact factor: 4.388

7.  Effects of Ultramicronized N-Palmitoylethanolamine Supplementation on Tramadol and Oxycodone Analgesia and Tolerance Prevention.

Authors:  Laura Micheli; Elena Lucarini; Alessandra Toti; Valentina Ferrara; Clara Ciampi; Carmen Parisio; Gianluca Bartolucci; Lorenzo Di Cesare Mannelli; Carla Ghelardini
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

8.  Inhibition of Monoacylglycerol Lipase by NSD1819 as an Effective Strategy for the Endocannabinoid System Modulation against Neuroinflammation-Related Disorders.

Authors:  Laura Micheli; Samuele Maramai; Alessandra Toti; Valentina Ferrara; Clara Ciampi; Lorenzo Di Cesare Mannelli; Carla Ghelardini
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

9.  Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  M Cervigni; L Nasta; C Schievano; N Lampropoulou; E Ostardo
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.